Evidence map›Paper›PMID 37043578›Full record

ArticleScience advances2023

CD34

Yuwei Song, Junyao Yang, Tianrun Li, Xiaotong Sun, Ruoran Lin, Yangyan He, Kai Sun, Jingyan Han, Guangxin Yang, Xuan Li and 12 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Foxs1-mediated transformation of CD34EMBO molecular medicine · 2026
    Article
  4. Liver Kinase B1 in CD11cAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. FMO2 Promotes Angiogenesis via Regulation of N-Acetylornithine.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. IL-33-Induced TREM2Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Yuwei SongDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China.ORCID 0000-0002-4956-227X
Junyao YangDepartment of Clinical Laboratory, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0003-3307-704X
Tianrun LiDepartment of Interventional Radiology and Vascular Surgery, Peking University Third Hospital, Beijing, China.ORCID 0000-0002-1947-640X
Xiaotong SunDepartment of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0002-1178-8011
Ruoran LinDepartment of Vascular Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0003-1024-6437
Yangyan HeDepartment of Vascular Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Kai SunDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China.
Jingyan HanDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China.
Guangxin YangDepartment of Interventional Radiology and Vascular Surgery, Peking University Third Hospital, Beijing, China.ORCID 0000-0002-9540-8089
Xuan LiDepartment of Interventional Radiology and Vascular Surgery, Peking University Third Hospital, Beijing, China.
Bo LiuDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China.
Dongmin YangDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China.
Guohui DangDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China.ORCID 0000-0002-5377-0637
Xiaolong MaDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China.ORCID 0000-0002-3151-4261
Xing DuDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China.ORCID 0000-0001-5786-1758
Bohuan ZhangDepartment of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yanhua HuDepartment of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wei KongDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China.
Xian WangDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China.
Hongkun ZhangDepartment of Vascular Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0003-1762-8614
Qingbo XuDepartment of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0002-6414-2273
Juan FengDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China.ORCID 0000-0003-0174-4784
Peking University · CNFirst Affiliated Hospital Zhejiang University · CNXinHua Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD34

Indexed as

IschemiaSignal TransductionAnimalsFibroblastsHumansMacrophagesMiceOncostatin MOncostatin MOSM protein, human

Identifiers

PMID37043578
PMCPMC12488030
OpenAlexW4365140302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.